Xeris Biopharma Holdings Intangible Assets

Xeris Biopharma Holdings (XERS) currently reports a intangible assets of $83M as of June 2026. That compares with $94M in the prior-year period — down 11.6% year over year. Use the charts on this page to explore Xeris Biopharma Holdings's intangible assets history and peer comparisons.

Xeris Biopharma Holdings's intangible assets decreased from $94M to $83M — a 11.6% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Xeris Biopharma Holdings reported $83M in intangible assets as of June 2026. That compares with $94M in the prior-year period — down 11.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $83M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Xeris Biopharma Holdings, and consider following XERS for alerts when major investors trade the stock.

Xeris Biopharma Holdings is classified in the Healthcare sector. On intangible assets, it currently shows $83M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing XERS with unrelated industries.